V
Vistagen Therapeutics (VTGN)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Vistagen Therapeutics (VTGN)
Vistagen Therapeutics Inc. is a late clinical-stage biopharmaceutical company. The Company focuses on transforming the treatment landscape for individuals living with anxiety depression and other central nervous system (CNS) disorders. It is advancin... Read more
- USD2.85
- USD2.92
- USD2.84
- USD3.79
- 19.30%
- 1M
- 173.32k
- 413.69k
- 89M
- 1.90
- -16.70%
Stock News
3 hours ago
Is It Too Late To Consider Buying Tapestry, Inc. (NYSE:TPR)?
Yahoo
5 hours ago
Starbucks And McDonald's: Fast Food Giant Better Positioned Amid China Challenges
SeekingAlpha
5 hours ago
An analyst just upgraded a cybersecurity stock that we've been pounding the table on
CNBC
5 hours ago
Tesla's Stock Should Be 10 Times Cheaper (Rating Downgrade)
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
